Nancy Chang

Nancy Chang General Information

Description

Dr. Nancy Chang serves as Chief Executive Officer & Chairperson of the Board at Ansun Biopharma. Dr. Chang serves as Chief Executive Officer at Anovac. Dr. Chang served as Co-Chief Executive Officer and Chairperson of the Board. She is an Angel Investor. Dr. Chang serves as an Emeritus Member at GOOSE Capital. She serves as a venture partner at magnet ventures. She served as an Advisor at 3E Bioventures Capital. She serves as a Board Member & Advisor at Avirmax. She was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors from 2007 to 2012. From 1987 to 2007, she served as an Advisor at Emerging Technology Partners (Venture Capital). She served as Co-Founder, President, and Chairman of Tanox, Inc., which was sold to Genentech in 2007. Before founding Tanox, she held several leadership positions at Centocor, now a division of Johnson & Johnson. She was also an Associate Professor at Baylor College of Medicine. She has served on the board of several companies, including SciClone Pharmaceuticals, Inc., Charles River Laboratories International, Inc., and Applied Optoelectronics Inc. She received her Doctorate in Biological Chemistry from Harvard University.